New SPAC: Oaktree Acquisition Corp. III Life Sciences (OACCU) Files for $175M IPO

new-spac

New SPAC: Oaktree Acquisition Corp. III Life Sciences (OACCU) Files for $175M IPO

Oaktree III Life Sciences (NASDAQ:OACCU) has filed for a $175 million SPAC with some of the most aggressively team-friendly terms seen so far in the second half of 2024. The new SPAC’s units contain 1/5 warrants and the trust is not set to be overfunded. Only the warrantless Cantor Equity Partners (NASDAQ:CEP) has IPO’d so
Read More

To access this post, you must purchase 1 - User: Monthly Plan.